ExploreWatchlistsPricing
  1. JP-listed companies
  2. CanBas Co.,Ltd.
  3. Financials
  4. Earnings per share

CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Jun 30, 2025-61.1-9.96%
Jun 30, 2024-67.9-18.22%
Jun 30, 2023-83-5.98%
Jun 30, 2022-88.3+26.14%
Jun 30, 2021-70-16.30%
Jun 30, 2020-83.6+8.54%
Jun 30, 2019-77.1-20.31%
Jun 30, 2018-96.7+15.99%
Jun 30, 2017-83.4-2.80%
Jun 30, 2016-85.8+37.23%
Jun 30, 2015-62.5-38.39%
Jun 30, 2014-101.4-48.97%
Jun 30, 2013-198.8-48.32%
Jun 30, 2012-384.7-25.44%
Jun 30, 2011-515.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat